ArticleHaematologica2024

Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent.

Nickolas Steinauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.